CHINESE MEDICINE FOR PULMONARY FIBROSIS: A BIBLIOMETRIC REVIEW FROM 2005 TO 2023

Yıl 2023, Cilt: 2 Sayı: 2, 1 - 12, 01.10.2023

Xiaodi Lv Bin Wang Gao Zhen Weifeng Tang Jingcheng Dong Ying Wei

Öz

To enhance our comprehension of the progression in the field of Chinese medicine for pulmonary fibrosis (PF), to grasp the
fundamental shift in the understanding of role of Chinese medicine in PF management, to delve into potential and efficacious
pharmacological mechanisms for PF, and to uncover innovative diagnostic targets, we employed a bibliometric analysis to examine
articles pertaining to Chinese medicine for PF published between 2005 and 2023. Drawing upon information derived from the Web
of Science Core Collection spanning the years 2005 to 2023, a thorough compilation of 389 articles focused on Chinese medicine
for PF has been identified, distributed across an array of 389 scholarly journals. These contributions were authored by 2334
individuals associated with 395 organizations representing diverse regions, encompassing 16 distinct countries or territories. Our
findings shed light on the evolution of traditional Chinese medicine's application and research in effective PF therapy, the evolving
paradigm guiding this domain, the exploration and integration of novel mechanisms, and the emerging frontiers within this realm.

Anahtar Kelimeler

pulmonary fibrosis, Chinese medicine, targets, bibliometric analysis

Kaynakça

• Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. The Lancet. 2017;389(10082):1941-52.
• Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. New England Journal of Medicine. 2020;383(10):958-68.
• Cobo MJ, López‐Herrera AG, Herrera‐Viedma E, et al. Science mapping software tools: Review, analysis, and cooperative study among tools. Journal of the American Society for information Science and Technology. 2011;62(7):1382-402.
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research. 2003;13(11):2498-504.
• Jiménez-Marín Á, Collado-Romero M, Ramirez-Boo M, et al., editors. Biological pathway analysis by ArrayUnlock and ingenuity pathway analysis. BMC proceedings; 2009: Springer.
• Van Eck N, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. scientometrics. 2010;84(2):523-38.
• Garfield E. Historiographic mapping of knowledge domains literature. Journal of Information Science. 2004;30(2):119-45.
• Börner K, Huang W, Linnemeier M, et al. Rete-netzwerk-red: analyzing and visualizing scholarly networks using the Network Workbench Tool. Scientometrics. 2010;83(3):863-76.
• Morris SA, Yen G, Wu Z, et al. Time line visualization of research fronts. Journal of the American society for information science and technology. 2003;54(5):413-22.
• Leydesdorff L, Schank T. Dynamic animations of journal maps: Indicators of structural changes and interdisciplinary developments. Journal of the American Society for Information Science and Technology. 2008;59(11):1810-8.
• Chen C, Ibekwe‐SanJuan F, Hou J. The structure and dynamics of cocitation clusters: A multiple‐perspective cocitation analysis. Journal of the American Society for information Science and Technology. 2010;61(7):1386-409.
• Chen C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for information Science and Technology. 2006;57(3):359-77.
• Chen C, Song I-Y, Yuan X, et al. The thematic and citation landscape of data and knowledge engineering (1985–2007). Data & Knowledge Engineering. 2008;67(2):234-59.
• Chen C. Predictive effects of structural variation on citation counts. Journal of the American Society for Information Science and Technology. 2012;63(3):431-49.
• Brinker AM, Ma J, Lipsky PE, et al. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry. 2007;68(6):732-66. Cui W, Li L, Li D, et al. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial–mesenchymal transition. Inflammation Research. 2015;64:953-61.
• Shen Y, Zhao HL, Du J, et al. Feitai, a Chinese herbal medicine, reduces transforming growth factor‐β1 and monocyte chemoattractant protein‐1 expression in bleomycin‐induced lung fibrosis in mice. Clinical and experimental pharmacology and physiology. 2005;32(12):1071-7.
• An SM, DIng QP, Li L-s. Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways. Acta Pharmacologica Sinica. 2013;34(6):777-83.
• Yang J, Cui Y, Kolb M. How useful is traditional herbal medicine for pulmonary fibrosis? Respirology. 2009;14(8):1082-91.
• Zhang XM, Sun XS, Jiang LD, Yang XH, Zhou PA. Treatment of idiopathic pulmonary fibrosis with Qi-hong Decoction. J. Beijing Univ. Tradit. Chin. Med. (Clin. Med.) 2007; 14: 9–11. [Article in Chinese].
• Qiu ZN, Pan JH, Yu QH. Treatment of idiopathic pulmonary fibrosis with Tao-er-dan decoction. Sci. Tradit. Chin. Med. 2002; 9: 174–5. [Article in Chinese].
• Liu LL, Zhang K, Ou JQ. The effect of Bu-shen-yi-fei-fang combining small dose prednisone on pulmonary fibrosis secondary to rheumatoid arthritis. J. Liaoning Tradit. Chin. Med. 2006; 33: 849–50. [Article in Chinese].
• Li H, Du S, Yang L, et al. Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen. Innate immunity. 2009;15(3):143-54.
• Gauldie J, Kolb M, Ask K, et al. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proceedings of the American Thoracic Society. 2006;3(8):696-702.
• Wong C, Lam C, Wu A, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical & Experimental Immunology. 2004;136(1):95-103.
• Glass WG, Subbarao K, Murphy B, et al. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARSCoV) pulmonary infection of mice. The Journal of Immunology. 2004;173(6):4030-9.
• Zhou X-M, Huang M-M, He C-C, et al. Inhibitory effects of citrus extracts on the experimental pulmonary fibrosis. Journal of ethnopharmacology. 2009;126(1):143-8.
• Zhang H-Q, Yau Y-F, Szeto K-Y, et al. Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis. Journal of ethnopharmacology. 2007;109(3):543-6.
• Tang D, Kang R, Livesey KM, et al. Endogenous HMGB1 regulates autophagy. Journal of Cell Biology. 2010;190(5):881-92.
• Oruqaj G, Karnati S, Kotarkonda LK, et al. Transforming Growth Factor-β1 Regulates Peroxisomal Genes/Proteins via Smad Signaling in Idiopathic Pulmonary Fibrosis Fibroblasts and Transgenic Mouse Models. The American Journal of Pathology. 2023;193(3):259-74.
• Ng L-T, Yen F-L, Liao C-W, et al. Protective effect of Houttuynia cordata extract on bleomycin-induced pulmonary fibrosis in rats. The American journal of Chinese medicine. 2007;35(03):465-75.
• Du S, Li H, Cui Y, et al. Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway. International Immunopharmacology. 2012;13(3):331-40.
• Zhai H, Hhang J, Gao M, et al. Comparative study between Ephedra sinica Stapf and Fructus Schisandrae Chinensis on ET-1 and 6-ketoprostaglandin F1α in rats with idiopathic pulmonary fibrosis. Genetics and Molecular Research. 2014;13(2):3761-71.
• Chen M, Cheung FW, Chan MH, et al. Protective roles of Cordyceps on lung fibrosis in cellular and rat models. Journal of ethnopharmacology. 2012;143(2):448-54.
• Zhao P, Zhou W-C, Li D-L, et al. Total glucosides of Danggui Buxue Tang attenuate BLM-induced pulmonary fibrosis via regulating oxidative stress by inhibiting NOX4. Oxidative Medicine and Cellular Longevity. 2015;2015.
• Gao M, Zhang J-H, Zhou F-X, et al. Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF-β1. Oncology reports. 2012;27(2):585-93.
• Menou A, Duitman J, Crestani B. The impaired proteases and anti-proteases balance in Idiopathic Pulmonary Fibrosis. Matrix Biology. 2018;68:382-403.